Title:
COMBINATION THERAPY INVOLVING ANTI-CD39 ANTIBODIES AND ADOPTIVE CELL THERAPY
Document Type and Number:
WIPO Patent Application WO/2021/203058
Kind Code:
A3
Abstract:
Provided is an antibody combination therapy with an anti-CD39 antibody and an adoptive cell therapy.
Inventors:
BEERS COURTNEY (US)
MOESTA ACHIM (US)
MALANDRO NICOLE (US)
MOESTA ACHIM (US)
MALANDRO NICOLE (US)
Application Number:
PCT/US2021/025661
Publication Date:
November 25, 2021
Filing Date:
April 02, 2021
Export Citation:
Assignee:
TRISHULA THERAPEUTICS INC (US)
International Classes:
A61K35/17; A61K39/395; A61P35/00; C07K16/28
Domestic Patent References:
| WO2018223101A1 | 2018-12-06 | |||
| WO2019027935A1 | 2019-02-07 | |||
| WO2019241707A1 | 2019-12-19 | |||
| WO2019160829A1 | 2019-08-22 |
Foreign References:
| US20150275209A1 | 2015-10-01 | |||
| US20160137747A1 | 2016-05-19 |
Attorney, Agent or Firm:
ANDERTON, H. Thomas (US)
Download PDF:
Previous Patent: POWDER HYDRATION SYSTEMS WITH MIXING APPARATUS AND METHODS OF USE
Next Patent: VALIDATION OF HEALTH STATUS INFORMATION
Next Patent: VALIDATION OF HEALTH STATUS INFORMATION